HSTO
Income statement / Annual
Last year (2022), Histogen Inc.'s total revenue was $3.77 M,
an increase of 310.12% from the previous year.
In 2022, Histogen Inc.'s net income was -$10.62 M.
See Histogen Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$3.77 M
|
$919,000.00
|
$2.06 M
|
$11.30 M
|
$33.59 M
|
$35.38 M
|
$799,046.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$220,000.00 |
$968,000.00 |
$2.22 M |
$0.00 |
-$4.00 |
-$4.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$3.77 M |
$699,000.00 |
$1.09 M |
$9.09 M |
$33.59 M |
$35.38 M |
$799,050.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
1 |
0.76 |
0.53 |
0.8 |
1 |
1 |
1 |
0 |
0 |
0 |
| Research and Development
Expenses |
$5.02 M
|
$8.47 M
|
$6.22 M
|
$4.10 M
|
$41.37 M
|
$43.22 M
|
$20.29 M
|
$16.30 M
|
$14.91 M
|
$6.95 M
|
| General & Administrative
Expenses |
$9.39 M
|
$7.80 M
|
$6.59 M
|
$6.21 M
|
$10.50 M
|
$9.71 M
|
$10.34 M
|
$7.83 M
|
$7.38 M
|
$4.65 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$91,000.00
|
-$108,299.00
|
-$105,839.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$9.39 M
|
$7.80 M
|
$6.59 M
|
$6.21 M
|
$10.40 M
|
$9.60 M
|
$10.23 M
|
$7.83 M
|
$7.38 M
|
$4.65 M
|
| Other Expenses |
$0.00 |
-$113,000.00 |
$105,000.00 |
-$150,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$14.27 M |
$16.16 M |
$12.81 M |
$10.16 M |
$51.77 M |
$52.82 M |
$30.52 M |
$24.13 M |
$22.29 M |
$11.60 M |
| Cost And Expenses |
$14.41 M |
$16.38 M |
$13.77 M |
$12.37 M |
$51.86 M |
$52.93 M |
$30.63 M |
$24.13 M |
$22.29 M |
$11.60 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$568,000.00 |
$962,000.00 |
$892,178.00 |
$138,413.00 |
$67,885.00 |
$0.00 |
$0.00 |
| Interest Expense |
$1,000.00 |
$10,000.00 |
$64,000.00 |
$0.00 |
$696,000.00 |
$662,395.00 |
$70,000.00 |
$70,000.00 |
$70,000.00 |
$462,570.00 |
| Depreciation &
Amortization |
$140,000.00
|
$97,000.00
|
$98,000.00
|
$145,000.00
|
$91,000.00
|
$108,303.00
|
$105,841.00
|
$67,860.00
|
-$538,900.00
|
$10,446.00
|
| EBITDA |
-$10.50 M
|
-$14.90 M
|
-$18.66 M
|
-$2.86 M
|
-$17.22 M
|
-$16.63 M
|
-$29.56 M
|
-$24.01 M
|
-$22.79 M
|
-$15.14 M
|
| EBITDA Ratio |
-2.79 |
-16.81 |
-2.22 |
0.09 |
-0.54 |
-0.49 |
-37.2 |
0 |
0 |
0 |
| Operating Income Ratio
|
-2.82
|
-16.82
|
-5.69
|
0.08
|
-0.54
|
-0.5
|
-37.33
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$1,000.00
|
$448,000.00
|
-$7.10 M
|
-$1.93 M
|
$267,000.00
|
$154,067.00
|
$98,329.00
|
-$17,924.00
|
$0.00
|
-$4.02 M
|
| Income Before Tax |
-$10.64 M |
-$15.01 M |
-$18.82 M |
-$3.00 M |
-$18.01 M |
-$17.40 M |
-$29.73 M |
-$24.15 M |
-$22.32 M |
-$15.62 M |
| Income Before Tax Ratio
|
-2.82
|
-16.33
|
-9.14
|
-0.27
|
-0.54
|
-0.49
|
-37.21
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$604,000.00 |
$6.96 M |
$1.90 M |
$963,000.00 |
$816,465.00 |
$168,320.00 |
$70,000.00 |
$70,000.00 |
$462,570.00 |
| Net Income |
-$10.62 M |
-$14.41 M |
-$25.77 M |
-$4.90 M |
-$18.01 M |
-$17.40 M |
-$29.73 M |
-$24.15 M |
-$22.32 M |
-$15.62 M |
| Net Income Ratio |
-2.82 |
-15.67 |
-12.52 |
-0.43 |
-0.54 |
-0.49 |
-37.21 |
0 |
0 |
0 |
| EPS |
-3.46 |
-7.51 |
-57.16 |
-8.29 |
-118.6 |
-121.71 |
-262.55 |
-1.3 |
-1.44 |
-2.12 |
| EPS Diluted |
-3.46 |
-7.51 |
-57.16 |
-8.29 |
-118.6 |
-121.71 |
-262.55 |
-1.3 |
-1.44 |
-2.12 |
| Weighted Average Shares
Out |
$3.21 M
|
$1.92 M
|
$450,918.00
|
$590,693.00
|
$151,850.00
|
$142,933.00
|
$113,249.00
|
$18.62 M
|
$15.48 M
|
$7.36 M
|
| Weighted Average Shares
Out Diluted |
$3.21 M
|
$1.92 M
|
$450,918.00
|
$590,693.00
|
$151,850.00
|
$142,933.00
|
$113,249.00
|
$18.62 M
|
$15.48 M
|
$7.36 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
